Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
EMBO Molecular Medicine|February 4, 2022
Identification of treatment-induced vulnerabilities in pancreatic cancer patients using functional model systemsKatja Peschke, Hannah Jakubowsky, Arlett Schäfer, et al.
Gut|February 1, 2020
SUMO pathway inhibition targets an aggressive pancreatic cancer subtypeAlexander Biederstädt, Zonera Hassan, Christian Schneeweis, et al.
JCI Insight|April 19, 2022
Epigenetic drug screening defines a PRMT5 inhibitor-sensitive pancreatic cancer subtypeFelix Orben, Katharina Lankes, Christian Schneeweis, et al.
The Journal of Pathology|April 4, 2022
Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatmentAlexander Hennig, Franziska Baenke, Anna Klimova, et al.
Cell Reports. Medicine|February 6, 2025
Disrupting AGR2/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapyHongzhen Li, Zhiheng Zhang, Zhao Shi, et al.
Nature Protocols|March 15, 2022
CRISPR somatic genome engineering and cancer modeling in the mouse pancreas and liverThorsten Kaltenbacher, Jessica Löprich, Roman Maresch, et al.
Cancer Discovery|September 7, 2018
Cholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer StemnessBernhard W Renz, Takayuki Tanaka, Masaki Sunagawa, et al.
Cell Reports|May 31, 2023
Resistance to mesenchymal reprogramming sustains clonal propagation in metastatic breast cancerMassimo Saini, Laura Schmidleitner, Helena Domínguez Moreno, et al.
Pageof 9